MedWatch

Novo Holdings beats record as value of assets exceeds EUR 90bn

Denmark’s biggest holding company had a splendid 2021, where investments resulted in a high return.

Photo: Novo Holdings / PR

It’s been a tremendous year for Novo Holdings, which saw nothing less than a total income of EUR 5bn, an increase of 29 percent compared to the preceding year, the company’s annual report states.

”2021 was a very satisfactory year for Novo Holdings. Besides strong returns from the Novo Group companies, our Investment Portfolio delivered strong results across all segments,” says CEO of Novo Holdings Katim Kutay in the report.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

CHMP to remove 100 generic medicines from market

Due to fraudulent clinical trials from a contract research organization, the EMA’s expert committee, the CHMP, is now suspending marketing approval authorizations for around 100 generic drugs on the market.

Further reading

Related articles

Latest news

See all jobs